The cytochromes P450 and mechanisms of chemical carcinogenesis. by Parke, D V
jo Reviews &commentariesS-t
The Cytochromes P450 and Mechanisms of
Chemical Carcinogenesis
Dennis V. Parke
Division of Molecular Toxicology, School of Biological Sciences, University of Surrey,
Guildford, GU2 5XH, UK
The insidious and lethal nature of cancer,
associated with its unique characteristics of
dedifferentiation and loss ofspecialist func-
tion, invasion, and metastasis, is the result
of changes in the chemical nature and
structure of the proteoglycans of the cell
glycocalyx and lysosomal enzymes, result-
ing from alterations in the highly specific
glycosylations ofthe glycosyl transferases of
the endoplasmic reticulum (1-3). These
changes in cell proteoglycans, among the
earliest changes seen in malignancy and
used for histological diagnoses ofpremalig-
nant states (4), are not only highly charac-
teristic of the disease but also contribute
progressively to the full establishment of
malignancy. Changes occur in the glycoca-
lyx, resulting in loss ofcell adhesion (5) or
in open intercellular tight junctions,
enabling toxic chemicals and reactive inter-
mediates to reach the critical basal cells of
epithelia. These changes may evoke perma-
nent DNA damage, resulting in a malig-
nant cell clone. Changes in cell adhesion
result in metastasis (3,6), and changes in
the proteoglycan hydrolases are associated
with tissue invasion (7,8). It is not insignif-
icant that these earliest changes in glycosyl
transferase activities and proteoglycan syn-
thesis occur in the endoplasmic reticulum,
the major site of metabolite activation of
chemical carcinogens and ofthe generation
of reactive oxygen species (ROS) from the
futile cycling of the microsomal cyto-
chromes. Furthermore, the endoplasmic
reticulum is believed to contain its own
DNA.
The categorization of cancer develop-
ment into the phases ofinitiation, promo-
tion, progression, and development is an
oversimplistic approach, since cancer, like
aging, is a process of continuous and pro-
gressive DNA degeneration (9,10) result-
ing from inherited impairment of DNA
protection, repair, and regulation, DNA
damage from ROS as in aging, and alkyla-
tion, arylation, and acylation of DNA by
chemical carcinogens. These processes
result in errors in transcription, leading to
mutations and activation of proto-onco-
genes (11), which are considered to be
genotoxic mechanisms, and also lead to
altered regulation of DNA transcription,
repair, and replication, often considered to
be nongenotoxic. Consequently, cancer is
probably the result ofseveral different fac-
tors including inherited tendencies, aging,
dietary deficiency in ROS scavengers and
antioxidants, and exposure to toxic envi-
ronmental chemicals. Putting aside inherit-
ed factors, which though most important
cannot readily be changed, the major
causative factors in cancer would appear to
be ROS associated with the aging process,
oxidative stress, degenerative disease, and
chemical carcinogens.
Chemical carcinogenesis has long been
associated with planar molecules, which
may intercalate with DNA; with oxidative
activation of the carcinogens by cyto-
chromes P450 to reactive intermediates,
which are electrophilic and bind covalently
to DNA, thus damaging the genetic mater-
ial and activating oncogenes; with the pro-
duction of ROS, which may directly dam-
age the DNA or activate carcinogens to
reactive intermediates; and with activation
ofthe protein kinase C cascade, leading to
the phosphorylation of key nuclear pro-
teins (transcription factors) involved in the
regulation of DNA replication, changes in
the epidermal growth factor, immunosup-
pression, dedifferentiation and hyperplasia
(12,13). The activation of chemical car-
cinogens to reactive intermediates (ultimate
carcinogens) is catalyzed primarily by
cytochrome P4501 (CYPI) (14,15), which
selectively accepts planar molecules (car-
cinogens) as substrates (16); oxygenates
them in conformationally hindered posi-
tions, thus forming highly reactive epox-
ides, which, however, are not easily detoxi-
fied by epoxide hydrolase, glutathione
transferase, and other detoxification
enzymes (16); and is regulated by a cytoso-
lic (steroidlike) receptor, the Ah receptor,
which binds some carcinogens and other
planar molecules to induce increased pro-
duction ofCYP1, Ah receptor protein, and
other enzymes by genomal depression and
also activates the protein kinase C cascade
(14). Although the majority ofknown car-
cinogenic chemicals are believed to be
metabolically activated by CYP1, the
nitrosamines and other small molecules are
activated by cytochrome P4502E1 (17).
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Other mechanisms, including the action of
prostaglandin synthetase (18), myeloperox-
idase, and ROS-mediated oxygenations, are
known to be equally effective in carcino-
gen activation. However, the unique piv-
otal role ofCYP1 in chemical carcinogene-
sis is due to its coordination with the regu-
latoryAh receptor, resulting in the normal,
low, non-injurious tissue levels of CYP1
being greatly augmented (1000-fold or
more) by enzyme induction (19). More-
over, this enhanced metabolic activation of
carcinogens by CYP1 to damage the DNA
coincides with the activation of protein
kinase C to augment DNA replication and
evoke hyperplasia, thus ensuring that the
faulty genetic information is preserved and
perpetuated in a clone of DNA-damaged
cells.
ROS can similarly damage DNA (20)
and may also result in activation ofprotein
kinase C, oncogene activation, and multi-
stage carcinogenesis (21). ROS are gener-
ated continuously in biological systems by
the low efficiency in the conversion of
chemical energy into work, the associated
electron leakage from membranes, and the
consequent reduction of 02 to superoxy
anion and other ROS. As ROS generation
depends on tissue 02 uptake, and this is
high in small animal species, the sponta-
neous formation of ROS is greatest in
small rodents (22). Furthermore, biologi-
cal systems have an antioxidant defense
system to prevent ROS leading to oxida-
tive stress, tissue damage, and mutations,
and this is critically dependent on tissue
glutathione concentrations. While small
rodents, especially mice, consume tissue
glutathione in chemical detoxification,
humans and larger animals more expedi-
ently use water and epoxide hydrolase to
detoxify carcinogenic epoxides, with the
overall consequence that rats and mice are
much more susceptible to the toxic effects
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of ROS, thereby exhibiting much higher
levels of spontaneous cancer and much
shorter life-spans than man and other large
animals (23). Production of ROS may be
greatly increased by futile cycling of the
microsomal cytochromes P450; even phe-
nobarbitone, which is regarded as a non-
carcinogen and is metabolized by CYP2B,
results in considerable ROS production,
which can potentiate the malignancy of
known carcinogens (e.g., dimethylni-
trosamine).
The extreme case ofP450 futile cycling
is seen with cytochrome P4502E1
(CYP2E1), an enzyme which is believed to
result in the oxygenation of difficult-to-
oxidize substrates (e.g., ethanol) by gener-
ating ROS in the vicinity of the substrate
(24,25). Enhancement ofCYP2E1 activity
(by substrate-induced stabilization of the
enzyme, not enzyme induction) leads to a
prolonged burst of ROS production that
can result in tissue necrosis, mutations,
malignancy, organ failure, and death.
Numerous chemicals are known to
enhance CYP2E1 activity [e.g., ethanol,
acetone, halothane, and many other small
halogenated chemicals (26)] and hence to
provoke ROS generation with consequent
toxicity and carcinogenicity in small
rodents. Indeed, inspection has revealed
that those chemicals that cause cancer in
rodents, especially mice, but not in larger
species, are mostly substrates of CYP2E1.
For the reasons given, these chemicals are
unlikely to result in oxidative stress in
humans and larger animals species, and are
therefore unlikely to constitute as serious a
carcinogenic hazard as substrates ofCYP1.
By using molecular parameters (molec-
ular planarity, collision diameters, frontier
orbital energies) that discriminate sub-
strates of CYPI and CYP2E1 from each
other and from those of other cyto-
chromes, a novel procedure (COMPACT)
has been developed to detect potential
genotoxic carcinogens (CYP1 substrates)
and rodent carcinogens (CYP2E1)
(22,27,28). The lack of concordance
between the Ames test for mutagens
(which detects mostly CYPI substrates)
and the rodent two-species assay (which
identifies both CYPI and CYP2E1 sub-
strates) is thus explained. Apart from this
development in cancer detection and pre-
vention, the understanding ofthe multifac-
torial mechanisms of chemical carcinogen-
esis has facilitated new preventive measures
and treatments, including inhibition of
CYPI (29,30), enhanced detoxification of
ROS (31,32), and dietary supplementation
with antioxidant nutrients (31,33,34).
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